CYCLERION THERAPEUTICS, INC. Tax Credit Carryforward, Amount
CYCLERION THERAPEUTICS, INC. (CYCN) had Tax Credit Carryforward, Amount of $10.80 million as of 2025-12-31, per its S-4/A filed 2026-07-22.
Financial Statements › Notes › Income Taxes
us-gaap:TaxCreditCarryforwardAmount · last filed 2026-07-22
- 2025-12-31: Tax Credit Carryforward, Amount $10.80M.
- 2024-12-31: Tax Credit Carryforward, Amount $10.80M.
- 2023-12-31: Tax Credit Carryforward, Amount $10.80M.
- 2022-12-31: Tax Credit Carryforward, Amount $10.20M.
| Period end | Tax Credit Carryforward, Amount | Tax Credit Carryforward, Amount as first filed |
|---|---|---|
| 2025-12-31 | $10.80M S-4/A · filed 2026-07-22 | |
| 2024-12-31 | $10.80M 10-K/A · filed 2025-11-12 | |
| 2023-12-31 | $10.80M 10-K · filed 2024-03-05 | |
| 2022-12-31 | $10.20M 10-K · filed 2024-03-05 | |
| 2021-12-31 | $8.40M 10-K · filed 2023-03-22 | $8.40K 10-K · filed 2022-02-24 |
| 2020-12-31 | $7.50K 10-K · filed 2022-02-24 | $7.50M 10-K · filed 2021-02-25 |
| 2019-12-31 | $3.80M 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |